Greenwich LifeSciences, Inc.
NASDAQ:GLSIBiotechnology
Healthcare
$19.79 -3.08%
-$0.74 today
- Market cap
- $290.48M
- Beta
- 1.38
- P/E (TTM)
- -15.6
- EPS (TTM)
- -$1.49
52W Low $7.78High $34.10
Volume 0.23M
Average 0.14M
Balance Sheet
Inspect the capital base behind the business.
Assets
-$6.74M
FY 2025 · Annual
Liabilities
$2.02M
FY 2025 · Annual
+29.3% YoYEquity
$1.79M
FY 2025 · Annual
-29.3% YoYBalance Sheet
USD
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $10.5M |
| Total Current Assets | $10.5M |
| Total Assets | $10.5M |
Analysis
Selected assets total $10.5M for Latest. The largest visible component is Cash & Equivalents at $10.5M, about 100.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| DEFA14A | DEFA14A filing | Oct 26, 2026 | |
| DEF 14A | DEF 14A filing | Oct 26, 2026 | |
| ARS | ARS filing | Oct 26, 2026 | |
| 10-Q | Quarterly report | Aug 11, 2026 | |
| 4 | Statement of changes in beneficial ownership | Jul 30, 2026 |
How much cash does GLSI have?
Greenwich LifeSciences, Inc. (GLSI) reported -$6.74M in cash and equivalents in fiscal 2025.
How much debt does GLSI carry?
Greenwich LifeSciences, Inc. (GLSI) reported $0.00 of total debt, with net debt of $6.74M.
Continue the stock analysis
Jump to another research area for this company.